A mathematical model for pattern of change in β-cell reserve and factors affecting residual reserve within the first 2 years of Type 1 diabetes

Journal of Endocrinological Investigation

Volumn 25, Issue 11, 2002, Pages 987-992

  Altuntas, Yuksel ^a,b  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Haznedar Mah   (Turkey)

Author keywords

Glucagon; Mathematical model; Stimulated C peptide; Type 1 diabetes; cell reserve

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; INSULIN DERIVATIVE; PANCREAS ISLET CELL ANTIBODY; REGULAR INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DISEASE DURATION; FEMALE; FLUID THERAPY; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MULTIPLE REGRESSION; PANCREAS ISLET BETA CELL; PUBERTY; SEX DIFFERENCE; TIME;

ADOLESCENT; ADULT; AGING; AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; GLUCAGON; HUMANS; ISLETS OF LANGERHANS; MALE; MATHEMATICS; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 0036958849     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344073     Document Type: Article

References (30)

1. Eisenbarth G.S. Type 1 diabetes mellitus: A chronic autoimmune disease. N. Engl. J. Med. 1986, 304: 1360-1368.
2. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001, 358: 221-229.
3. Gorsuch A.N., Spencer K.M., Lister J. et al. Evidence for a long prediabetic period in type 1 (insulin dependent) diabetes mellitus. Lancet 1981; 2: 1363-1365.
4. Kimpimäki T., Knip M. Disease-associated autoantibodies as predictive markers of type 1 diabetes mellitus in siblings of affected children. J. Pediatr. Endocrinol. Metab. 2001, 14 (1): 575-587.
5. Klöppel G., Drenck C.R., Carstensen A. et al. The beta cell mass at the clinical onset of type 1 diabetes. Behring Inst. Mitt. 1984, 75: 42-45.
6. Arslanian S., Becker D., Drash A. Diabetes mellitus in the child and adolescent. In: Kappy M.S., Blizzard R.M., Migeon C.J. (Eds.), The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Springfield, Charles C. Thomas Publlisher, 1994, p. 961.
7. Sperling M. Aspect of the etiology, prediction, and prevention of insulin dependent diabetes mellitus in childhood. Pediatr. Clin. North. Am. 1997, 44: 269-841.
8. Bonfanti R., Bazzigaluppi E., Calori G. et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus. Diabet. Med. 1998, 15: 844-850.
9. Martin S., Pawlowski B., Greulich B., Ziegler A.G., Mandrup-Poulsen T., Mahon J. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care 1992, 15: 66-74.
10. Yilmaz M.T., Devrim A.S., Biyal F. et al. Immunoprotection in spontaneous remission of type 1 diabetes: Long-term follow-up results. Diabetes Res. Clin. Pract. 1993, 19: 151-162.
11. Koivisto V.A., Leirisalo-Repo M., Ebeling P. et al. Seven years of remission in a type 1 diabetic patient. Diabetes Care 1993, 16: 990-995.
12. World Health Organization. WHO Study Group. Diabetes mellitus. Tech. Rep. Ser. 1985, 727: 1-113.
13. Bottazzo G.F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974, 2: 1279-1283.
14. Bompiani G., Giordano C., Galluzzo A. Metabolic and immunological parameters for monitoring immuno therapy in Type 1 diabetes. In: Andreani D., Kolb H., Pozzilli P. (Eds.), Immunotherapy of Type 1 Diabetes, John Wiley and Sons, Newyork, 1989, 7: p. 55.
15. Karlsson F.A., Berne C., Björk E. et al. Beta-cell activity and destruction in type 1 diabetes. Ups. J. Med. Sci. 2000, 105: 85-89.
16. Ludvigsson J., Hellstrom S. Autoantibodies in relation to residual insulin secretion in children with IDDM. Diabetes Res. Clin. Pract. 1997, 35: 81-89.
17. Foulis A.K., Stewart J.A. The pancreas in recent onset type 1 (insulin dependent) diabetes mellitus: Insulin content of islets, insulitis and associated changes in the exocrine aciner tissue. Diabetologia 1984, 26: 456-461.
18. Peig M., Gomis R., Ercilla G., Casamitjana R., Bottazzo G.F., Pujol-Borrel R. Correlation between residual beta cell function and islet cell antibodies in newly diagnosed type 1 diabetes. Diabetes 1989, 38: 1396-1401.
19. Warren S, Le Compte P.M., Legg M.A. The pathology of juvenile diabetes mellitus. In: The Pathology of Diabetes Mellitus. 1966, 20: p. 351.
20. Ferri G.L., Bloom S.R., Polak J.M. Morphology of the islet of Langerhans. In: Howard J.M., Jordon G.L., Reber H.A. (Eds.), Surgical Disease of Pancreas. Lea and Febiger, Philadelphia, 1987, p. 779.
21. Weir G.C., Laybutt D.R., Kaneto H., Bonner-Weir S., Sharma A. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes (Suppl.): 154-159.
22. Ciampi A., Schiffrin A., Thiffault J. et al. Cluster analysis of an insulin dependent diabetic cohort towards the definition of clinical subtypes. J. Clin. Epidemiol 1990, 43: 701-715.
23. Pozzilli P., Mesturino C.A., Crino A., Gross T.M., Jeng L.M., Visalli N. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? Eur. J. Endocrinol. 2001, 145: 757-761.
24. Eff C., Faber O., Deckert T. Persistent insulin secretion, assessed by plasma C-peptide estimation in long term juvenil diabetics with a low insulin requirement. Diabetologia 1978, 15: 169-172.
25. Malone J.I. Growth and sexual maturation in children with insulin-dependent diabetes mellitus. Cur. Opin. Pediatr. 1993, 5: 494-498.
26. Dunger D.B. Diabetes in puberty. Arch. Dis. Child. 1992, 67: 569-573.
27. Dahlquist G. The aetiology of type 1 diabetes: An epidemiologial perspective. Acta. Pediatr. 1998, 425: 5-10.
28. Arslanian S.A., Heil B.V., Becker D.J., Drash A.L. Sexual dimorphism in insulin sensitivity in adolescent with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1991, 72: 920-926.
29. Blom L., Person L.A., Dahlquist G. A higher linear growth is associated with an increased risk of childhood diabetes mellitus. Diabetologia 1992, 35: 528-533.
30. Kandemir N., Acikgoz E., Yordam N. The epidemiology of juvenile-onset insulin dependent diabetes mellitus in Turkish children: A retrospective analysis of 477 cases. Turk. J. Pediatr. 1994, 36: 191-195.